He is senior executive director at GSK Pharmaceuticals. Mehernosh B. Kapadia features among "India’s Best CFOs (chief financial officer) in the Business Today — YES Bank listing of the country’s top corporate financial honchos. In its cover story entitled "The Money Meisters” (July 24, 2011), the magazine notes that Kapadia is "soft-spoken, extremely patient and prudent” and it is these qualities "that have helped him transform GSK Pharmaceuticals, or GSK Pharma, and keep it at pole position.” "The CFO of any modern corporation is right up there beside the Chief Executive Officer in power, responsibility and accountability. The British got it right a long time ago — the Chancellor of the Exchequer lives at No. 11 Downing Street, next door to the Prime Minister. No wonder many CFOs make an effortless transition to the chief executive’s office,” editor Chaitanya Kalbag analyses in his editorial.
Mehernosh B. Kapadia: transforming GSK Pharma
Kapadia is among the 12 men and one woman selected by a "very finicky jury.” He was adjudged the winner in the category of "Best Transformation Agent” in the mid-size company segment, with Larsen and Toubro’s Y. M. Deosthalee the winner in the same category among large companies. GSK Pharma has been on a more robust growth path over the last three years compared to previous years. "Sales are vanity, profit is sanity and cash is king” is Kapadia’s favorite aphorism (concise observation, pithily stated), the magazine states, crediting him for playing a key role in allocating resources, expanding the field force and ensuring the right product mix.